OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Organon & Co. for alleged violations of federal securities laws, claiming that the company made materially false and misleading statements regarding its business and operations during the class period from October 31, 2024, to April 30, 2025 [1][2][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Organon securities during the specified class period [2]. - Allegations include that Organon provided overly positive statements while concealing material adverse facts, particularly regarding capital allocation and a significant reduction in quarterly dividends [3]. - The complaint highlights that following the revelation of these issues, Organon's common stock price experienced a dramatic decline [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Organon have until July 22, 2025, to request to be appointed as lead plaintiff in the case [4]. - A copy of the complaint can be reviewed on the law firm's website [4]. Group 3: Legal Representation - The law firm representing the investors operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5]. - Bronstein, Gewirtz & Grossman, LLC is noted for recovering hundreds of millions of dollars for investors in similar cases [6].